StockHighAlert-
5年前
"We're impressed with Mr. Sonoga's experience, resources, and relationships, as well as the results he's achieved for other companies. We're excited to be working with him," stated Gavin Collier, Chief Executive Officer of Nass Valley Gateway. "In order to broaden our shareholder base, Mr. Sonoga will launch an investor awareness program that will effectively communicate our unique value proposition, as well as uniqueness in the marketplace and commitment to a consumer-centric business model; providing a consistent, high quality, and healthy experience for our customers to the investment community."
StockHighAlert-
5年前
Todd D. Sonoga is the former Sr. Executive and Assistant Editor for Wall Street Publishing (The Small Cap Report) and the general partner for Trilogy Marketing Strategies, LLC. Trilogy was a public relations firm specializing in consulting, raising market awareness, market support and identifying M&A targets for small cap companies. Mr. Sonoga is a Consultant, Investor and Entrepreneur. He founded Trilogy Marketing Strategies in 1998, Wall Street Micro Cap in 2013, Crowd Funding Power in 2014 and in January 2017, Mr. Sonoga assumed the role of Chief Marketing Officer and Co-Founder for WFN1 News Corp. and the radio show "CEO Money," airing daily on IHeart's Talk Radio 1190 AM Dallas/Fort Worth.
Mr. Sonoga has successfully represented public and private companies for over 20 years, consulting with them on market awareness, support, raising capital and identifying merger and acquisition targets.
"I am so impressed by the uniqueness of the company's products, commitment and the dedication of the management team to deliver value to not only their customers and partners but equally as important their shareholders," stated Mr. Sonoga.
StockHighAlert-
5年前
$NSVGF Nass Valley Gateway Ltd. Engages Investor Relations Expert Todd Sonoga to Head Up Investment Community Awareness Efforts for the Company
VANCOUVER, Nov. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nass Valley Gateway Ltd. (CSE: "NVG") (OTC Pink: NSVGF) (Frankfurt: "3NVN") (the "Company" or "Nass Valley") today announced it has retained Investor Relations expert Todd D. Sonoga, to spearhead our investment community awareness efforts.
"We're impressed with Mr. Sonoga's experience, resources, and relationships, as well as the results he's achieved for other companies. We're excited to be working with him," stated Gavin Collier, Chief Executive Officer of Nass Valley Gateway. "In order to broaden our shareholder base, Mr. Sonoga will launch an investor awareness program that will effectively communicate our unique value proposition, as well as uniqueness in the marketplace and commitment to a consumer-centric business model; providing a consistent, high quality, and healthy experience for our customers to the investment community."
Todd D. Sonoga is the former Sr. Executive and Assistant Editor for Wall Street Publishing (The Small Cap Report) and the general partner for Trilogy Marketing Strategies, LLC. Trilogy was a public relations firm specializing in consulting, raising market awareness, market support and identifying M&A targets for small cap companies. Mr. Sonoga is a Consultant, Investor and Entrepreneur. He founded Trilogy Marketing Strategies in 1998, Wall Street Micro Cap in 2013, Crowd Funding Power in 2014 and in January 2017, Mr. Sonoga assumed the role of Chief Marketing Officer and Co-Founder for WFN1 News Corp. and the radio show "CEO Money," airing daily on IHeart's Talk Radio 1190 AM Dallas/Fort Worth.
Mr. Sonoga has successfully represented public and private companies for over 20 years, consulting with them on market awareness, support, raising capital and identifying merger and acquisition targets.
"I am so impressed by the uniqueness of the company's products, commitment and the dedication of the management team to deliver value to not only their customers and partners but equally as important their shareholders," stated Mr. Sonoga.
ABOUT NASS VALLEY
Nass Valley Gateway (CSE: "NVG") (OTC Pink: NSVGF) (Frankfurt: "3NVN") is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. ("PTI") which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol ("THC") content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited ("ABL").
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25-year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico, who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept of its ABL-Business and to aggressively focus on the hemp-based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jersey operations internationally.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
Company: Nass Valley Gateway Ltd.
422 Richards Street, Suite 170
V6B 2Z Vancouver
Canada
Phone: +1 (604) 617-6794
E-mail: info@nassvalleygateway.net
Internet: www.nassvalleygateway.com
StockHighAlert-
5年前
$NSVGF Nass Valley Gateway Ltd. Engages Investor Relations Expert Todd Sonoga to Head Up Investment Community Awareness Efforts for the Company
VANCOUVER, Nov. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nass Valley Gateway Ltd. (CSE: "NVG") (OTC Pink: NSVGF) (Frankfurt: "3NVN") (the "Company" or "Nass Valley") today announced it has retained Investor Relations expert Todd D. Sonoga, to spearhead our investment community awareness efforts.
"We're impressed with Mr. Sonoga's experience, resources, and relationships, as well as the results he's achieved for other companies. We're excited to be working with him," stated Gavin Collier, Chief Executive Officer of Nass Valley Gateway. "In order to broaden our shareholder base, Mr. Sonoga will launch an investor awareness program that will effectively communicate our unique value proposition, as well as uniqueness in the marketplace and commitment to a consumer-centric business model; providing a consistent, high quality, and healthy experience for our customers to the investment community."
Todd D. Sonoga is the former Sr. Executive and Assistant Editor for Wall Street Publishing (The Small Cap Report) and the general partner for Trilogy Marketing Strategies, LLC. Trilogy was a public relations firm specializing in consulting, raising market awareness, market support and identifying M&A targets for small cap companies. Mr. Sonoga is a Consultant, Investor and Entrepreneur. He founded Trilogy Marketing Strategies in 1998, Wall Street Micro Cap in 2013, Crowd Funding Power in 2014 and in January 2017, Mr. Sonoga assumed the role of Chief Marketing Officer and Co-Founder for WFN1 News Corp. and the radio show "CEO Money," airing daily on IHeart's Talk Radio 1190 AM Dallas/Fort Worth.
Mr. Sonoga has successfully represented public and private companies for over 20 years, consulting with them on market awareness, support, raising capital and identifying merger and acquisition targets.
"I am so impressed by the uniqueness of the company's products, commitment and the dedication of the management team to deliver value to not only their customers and partners but equally as important their shareholders," stated Mr. Sonoga.
ABOUT NASS VALLEY
Nass Valley Gateway (CSE: "NVG") (OTC Pink: NSVGF) (Frankfurt: "3NVN") is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. ("PTI") which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol ("THC") content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited ("ABL").
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25-year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico, who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept of its ABL-Business and to aggressively focus on the hemp-based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jersey operations internationally.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
Company: Nass Valley Gateway Ltd.
422 Richards Street, Suite 170
V6B 2Z Vancouver
Canada
Phone: +1 (604) 617-6794
E-mail: info@nassvalleygateway.net
Internet: www.nassvalleygateway.com
StockHighAlert-
5年前
Nass Valley Gateway LTD is a publicly traded company on the CSE (NVG) and the Frankfurt stock exchange (3NVN) in the Life Sciences category. In 2018, Nass Valley Gateway merged with Advanced Bioceuticals Limited, a company focused on the development of a fully-integrated strategy to bring organic, hemp-based, CBD products to market. These products now will be sold under the Nass Valley Gardens?, DermaPharm?, and The Duchess? brands via retail, wholesale, direct response, and digital sales channels.
ABL has established a successful central clearing house that services over 800,000 patients with chronic pain and is strategically placed to expand to over 5 million patients nationwide.
Our proprietary technology has streamlined our capacity to operate in multiple states under multiple facilities permitted and licensed to offer such services to this vastly growing patient base of patients who are underserviced and deterred by the opioid crisis.
Furthermore, our company invested in a consumer packaged goods CBD product line that is undeniably beneficial for our patients.
With our clearing house capacity to offer additional products and services to our active patients, the use of CBD as an alternative supplement for continued use, we are in a unique position to expand our initiatives in the CBD market.
There are many nuances and deterrence currently in the CBD market including full vertical supply chain vs. demand issues. Many companies rely on third party vendors that fail to execute in quality.
As a result, we have engaged a team of pharmacologists and nutritionists to strategically acquire our own production, manufacturing and distribution under cGMP CFR 111 guidance that can ensure our products are made under pharmaceutical quality testing and validation principles and further allow us to dictate our capacity to expand, without the lack of reliability in the market place.
Our goal is to cross-sell and convert a large portion of our patients to the topical and sublingual CBD alternative treatments and further engage with our patients’ doctors to acquire a triage of care under our compliance program to further provide pain relief.
Our shareholders will appreciate the combined experience of over 50 years in DME and CPG production and delivery, our customized CPG product intimately targeting our DME patients and further expand to additional DME patients and extrapolate our line to further distribution outlets.
Nass Valley Gateway Ltd, by way of ABL, shall have a national presence in CBD through our CPG line, a large volume influx of CBD patients converted from our database, and a supply chain under our control to ensure cGMP quality products are distributed consistently, meeting our expansion targets swiftly by way of future mergers, acquisitions and distribution agreements.
StockHighAlert-
5年前
$NVG Nass Valley Announces Changes to the Board of Directors
Trading Symbols
CSE: NVG
Deutsche Borse, Frankfurt : 3NVN
Germany : WKN A1JVHM/
ISIN CA6315202029
VANCOUVER , June 6, 2019 /CNW/ - Nass Valley Gateway Ltd. (the "Company" or "Nass Valley"), wishes to announce that the resignation of Milo Filgas as Director and member of the Company's audit committee had been confirmed on May 30, 2019 . The Company would like to thank Mr. Filgas for his contributions and is looking forward to continue working with him as a member of its Advisory Committee.
At the same board meeting Nass Valley also confirmed the appointment of Mr. Darren Palestine as his replacement in both board positions. Mr. Palestine received his Masters of Art Degree in "International Business" from the University of Florida in 2009 and is a Board Member of Commercial Finance Association (CFA)-Board Member since 2011 and has been managing the day to day business of "Commercial Finance Partners" as Managing Partner and COO since 2016.
The Company also wishes to announce the resignation of Mr. Eric Peter-Kaiser as Director and member of the Company's audit committee to be effective as of June 3, 2019 and the resignations of Messrs. Dieter Peter as Chairman and Director as well as Andrew von Kursell as Director and audit committee member effective June 5, 2019 .
Nass Valley acknowledges the contributions of all three gentlemen over the past few years, especially their respective positive involvement in administrative matters and keeping the company always in good standing.
The Company's President and CEO, Mr. John Peter Affenita commented, "We will announce the new appointments to the Board and open Committee positions very shortly and I am convinced that with the industry leading knowledge of its new team members Nass Valley will fulfil its objectives to be well positioned in the "Life Science" sector of the Canadian Securities Exchange and meet the challenges of its planned vertical integration within the CBD sector".
ABOUT NASS VALLEY
Nass Valley Gateway (CSE: "NVG"; Frankfurt : "3NVN") is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. ("PTI") which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol ("THC") content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited ("ABL").
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25 -year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico , who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept of its ABL-Business and to aggressively focus on the hemp-based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jersey operations internationally.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
SOURCE Nass Valley Gateway Ltd.
View original content: http://www.newswire.ca/en/releases/archive/June2019/06/c4665.html
StockHighAlert-
5年前
$NVG Nass Valley Gateway Enters into Letter of Intent with CSB Supply BV to Supply CBD Products for Distribution under Nass Valley's Brand
Trading Symbols: CSE: NVG
Deutsche Borse, Frankfurt: 3NVN
Germany: WKN A1JVHM/
ISIN CA6315202029
www.nassvalleygateway.com
VANCOUVER, May 6, 2019 /PRNewswire/ - Nass Valley Gateway Ltd. (the "Company" or "Nass Valley"), trading on the Canadian Securities Exchange ("CSE") under the trading Symbol "NVG" and on Deutsche Boerse Frankfurt under the trading Symbol 3NVN, is pleased to announce the signing of a letter of intent ("LOI") with CSB Supply BV ("CSB"). CSB is a global business to business wholesale supplier of CBD (Cannabidiol) products.
Under the terms of the LOI CSB will supply and Nass Valley will market and distribute CBD products nationally in the United States and Canada under the Nass Valley brand.
CSB is headquartered in Amsterdam and has been in business for over 10 years manufacturing, packaging and whole-selling a variety of CBD products. The products supplied for Nass Valley's brand will meet the US Federal legal requirements containing less than 0.3% THC (Tetrahydrocannabinol).
John Affenita, Nass Valley's President & CEO, commented: "We are very excited to be entering into this LOI with a prominent and well established CBD manufacturing company that meets the required quality and specification for Nass Valley's brand. The full range of products will be available for us to sell and distribute nationally and internationally. We believe that this partnership will be financially beneficial to both parties."
ABOUT NASS VALLEY
Nass Valley Gateway (CSE: "NVG"; Frankfurt: "3NVN") is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. ("PTI") which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol ("THC") content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited ("ABL").
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25 -year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico, who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept of its ABL-Business and to aggressively focus on the hemp-based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jersey operations internationally.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
Cision
Cision
More
View original content:http://www.prnewswire.com/news-releases/nass-valley-gateway-enters-into-letter-of-intent-with-csb-supply-bv-to-supply-cbd-products-for-distribution-under-nass-valleys-brand-300843842.html
StockHighAlert-
5年前
$NVG Nass Valley Announces Changes to Board of Directors
Trading Symbols
CSE: NVG
Deutsche Borse, Frankfurt : 3NVN
Germany : WKN A1JVHM/
ISIN CA6315202029
www.nassvalleygateway.com
VANCOUVER , May 2, 2019 /CNW/ - Nass Valley Gateway Ltd. (the "Company" or "Nass Valley"), announces that it has accepted the resignation of Dr. Samuel Alawieh as Director and COO of the Company and its Subsidiary Advanced Bioceuticals Limited ("ABL") for personal reasons, effective April 26, 2019. Nass Valley acknowledges Dr. Alawieh's contributions especially in ABL and wishes him the best with his future endeavours.
Nass Valley also wishes to announce the planned resignation of Milo Filgas as Director of the Company and its Audit Committee. Mr. Filgas' resignation is conditional upon the CSE acceptance of the "Personal Information Form" submitted by the newly nominated board member and highly qualified independent member of the Audit Committee. The Company would also thank Mr. Filgas for his contributions and is looking forward to continue working with him as a member of its Advisory Committee.
The Company's President and CEO, Mr. John Peter Affenita commented, "We will announce the new appointments to the Board very shortly and I am convinced that with the industry leading knowledge of its new team members Nass Valley will be well positioned to meet the challenges of its planned vertical integration within the CBD sector and the growing needs of our customers".
ABOUT NASS VALLEY
Nass Valley Gateway (CSE: "NVG"; Frankfurt : "3NVN") is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. ("PTI") which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol ("THC") content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited ("ABL").
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25 -year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico , who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept tof its ABL-Business and to aggressively focus on the hemp-based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jersey operations internationally.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
We seek Safe Harbor.
SOURCE Nass Valley Gateway Ltd.
View original content: http://www.newswire.ca/en/releases/archive/May2019/02/c0174.html
StockHighAlert-
5年前
$NVG Nass Valley Confirms its New CEO as President and Issues Incentive Stock Options
Trading Symbols
CSE: NVG
Deutsche Borse, Frankfurt : 3NVN
Germany : WKN A1JVHM/
ISIN CA6315202029
nassvalleygateway.com
VANCOUVER , April 15, 2019 /CNW/ - Nass Valley Gateway Ltd. (the "Company" or "Nass Valley"), wishes to announce that at its Board of Directors ("BoD") meeting held on April 10, 2019 the BoD has confirmed its new CEO, Mr. John Peter Affenita as President and CEO of the Company. The Company also established a Corporate Governance & Environment Committee consisting of three initial members which will be nominated and appointed during its next BoD meeting.
The Company is also pleased to announce that stock options have been granted to Directors, Officers, Committee Members and Consultants of the Company including its subsidiaries, to purchase up to an aggregate of 1,555,000 common shares of the Company. The stock options will be exercisable at a price of $0.18 per share with expiration date of April 10, 2022.
About Nass Valley
Nass Valley Gateway (CSE: "NVG"; Frankfurt : "3NVN") is a diversified healthcare company which is focused to further expand the business of its acquired subsidiary Pro-Thotics Technology Inc. ("PTI") which was established in 1988. The Company is increasing its marketing of durable medical equipment products (DME-Business) on a national level, to encompass all states of the USA and other areas of North America and is aggressively developing the marketing, production and vertical integration of Cannabidiol (CBD) products without Tetrahydrocannabinol ("THC") content for internal use including CBD infused skin, bath, and body care products of its wholly owned subsidiary Advanced Bioceuticals Limited ("ABL").
PTI is licensed to supply its products also to Medicare patients in the US and has established, over its more than 25 -year history, a database of more than 200,000 patients, located throughout the U.S. and Puerto Rico , who were seeking wellness from pain relief.
Through its subsidiary ABL, Nass Valley is determined to expand upon this pain relief concept tof its ABL-Business and to aggressively focus on the hemp based CBD marketplace with a global market of $3.1 billion (New Frontier Data) and expand its current New Jersey operations internationally.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
SOURCE Nass Valley Gateway Ltd.
View original content: http://www.newswire.ca/en/releases/archive/April2019/15/c7864.html
StockHighAlert-
5年前
Nass Valley Gateway Ltd. Announces that Trading of its Shares will Resume March 29, 2019
Trading Symbols: CSE: NVG
Deutsche Borse, Frankfurt: 3NVN
Germany: WKN A1JVHM/
ISIN CA6315202029
www.nassvalleygateway.com
VANCOUVER, March 28, 2019 /PRNewswire/ - Nass Valley Gateway Ltd. (the "Nass Valley" or "Company"), listed on the Canadian Securities Exchange ("CSE") under the trading Symbol "NVG" and on Deutsche Boerse Frankfurt under the trading Symbol 3NVN, is pleased to announce that after providing the necessary documentations for its announced fundamental change to the satisfaction of the CSE, its shares will resume trading on March 29, 2019.
The Company has completed the acquisition of two wholly owned subsidiaries Advanced Bioceuticals Limited ("ABL"), incorporated under the Laws of New Jersey and Pro-Thotics Technology Inc. ("PTI"), a New York corporation with a more than 25 year established business. Through PTI the Company will continue to focus on expanding the sale of Durable Medical Equipment ("DME-Products") and increasing its database of more than 200,000 patients with service of providing relief from pain and medical issues via its DME-Products. Through ABL the Company is determined to develop a business of hemp based Cannabidiol (CBD) products with zero Tetrahydrocannabinol (THC) content including CBD infused skin, bath, and body care products.
Nass Valley will not change its name and its shares will also continue to trade under the symbol "NVG". The Company's new team has worked relentlessly and persistently on satisfying the requirements of the Listing Statement in connection with the more complex matters regarding ABL's objectives in respect to its future CBD business.
John Affenita, Director and CEO, commented: "I am convinced that the Company's new team referred to in its News Release dated March 26, 2019, including all members of Nass Valley's subsidiaries ABL and PTI were not standing still during the trading-halt period and will continue to realize all proposed business objectives under the Company's new structure in the interest of all shareholders.
WE SEEK SAFE HARBOR.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
The securities being offered have not been, nor will be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to U.S. persons without registration or applicable exemption from the registration requirement of such Act. This release does not constitute an offer for sale of such securities in the United States of America.
Cision
Cision
More
View original content:http://www.prnewswire.com/news-releases/nass-valley-gateway-ltd-announces-that-trading-of-its-shares-will-resume-march-29-2019-300820762.html
Hot Features
プレミアム
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Red Horseshoe
3年前
Not2Day
4年前
otcrx3
5年前
